Microarray Kits Market by Product Type (DNA [cDNA, Oligo, BAC, SNP], RNA, Protein, Tissue), Application (Drug Discovery & Development, Research, Diagnostic), End User (CRO, Pharma & Biotech, Academic, Hospital & Diagnostic Lab)

List of Tables

The microarray kits market is projected to reach $2.51 billion by 2031, at a CAGR of 5.8% from 2024 to 2031.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the increasing research applications of microarrays, the use of microarrays in cancer research, the increasing adoption of personalized medicine, and the growing R&D expenditure in the pharmaceutical and biotechnology industries.

Furthermore, technological advancements in microarray technology and emerging economies provide a significant growth opportunity for this market. However, the higher costs of microarrays, as compared to other genetic methods, may restrain the growth of this market. Additionally, lack of sensitivity and accuracy pose a major challenge for the players operating in this market.

Among product type, in 2024, the DNA microarray kits segment is expected to account for the largest share of the market. DNA microarrays, also known as DNA chips or gene chips, are used in genomics and molecular biology for the simultaneous analysis of thousands to millions of DNA sequences, typically genes or oligonucleotide probes, on a small, solid support surface. The large market share of the segment is attributed to factors such as increasing incidence of cancer, wide application areas of microarray technology, rising funding for genomic R&D, and growing research for personalized medicine.

Among applications, in 2024, the drug discovery & development segment is expected to account for the largest share of the market. Drug discovery & development include the experiments that are conducted to test certain drugs or theories that can be applied to a particular disease treatment. The large market share of the segment is attributed to factors such as growing R&D expenditure, a large number of academic and research institutes focusing on cancer research, and growing innovations in the field of microarray technology.

Among end users, in 2024, the pharmaceutical and biotechnology companies segment is expected to account for the largest share of the market. Pharmaceutical and biotechnology companies use microarray kits and technology for various applications such as drug discovery, cancer biomarker detection, and personalized medicines. The large share of the market is attributed to factors such as a growing focus on drug discovery & development, and rising pharmaceutical R&D expenditure, and increased adoption of personalized medicines. In the case of personalized medicine, DNA microarray kits can be used to compare diseased tissues/cells with healthy tissues/cells in order to find the characteristics of a disease. In the case of drug discovery & development, protein microarray kits are used to screen patients and then prescribe drugs to exclude potential side effects and determine the most suitable dose, hence driving the growth of the segment.

An in-depth analysis of the geographical scenario of the global microarray kits market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the global microarray kits market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The largest share of the segment is primarily due to the availability of advanced infrastructure for genomic research, the presence of key players, the presence of key pharmaceutical companies and research institutes, availability of funding for life science research. The presence of key players in the market improves the accessibility to advanced microarray technology resources, including kits.

The key players operating in the global microarray kits market are Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Edvotek, Inc. (U.S.), Sakura Finetek USA, Inc. (U.S.), Dextra Laboratories Ltd. (U.K.), and GeneCopoeia, Inc. (U.S.).

Scope of the Report:

Microarray Kits Market-by Product Type

DNA Microarray Kits
- cDNA Microarray Kits
- Oligo Microarray Kits
- BAC Microarray Kits
- SNP Microarray Kits
RNA Microarray Kits
Protein Microarray Kits
Tissue Microarray Kits

Microarray Kits Market-by Application

Drug Discovery & Development
Research Applications
Diagnostics
Other Applications

(Other applications primarily include agriculture, food & beverages, and forensics)

Microarray Kits Market-by End User

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research & Academic Institutes
Hospitals & Diagnostic Laboratories
Other End Users

(Other end users primarily include veterinary clinics, agricultural industry, and forensic laboratories)

Microarray Kits Market-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe (RoE)
Asia-Pacific
- Japan
- China
- India
- Rest of APAC (RoAPAC)
Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
Middle East & Africa

Product Code: MRHC - 1041094

1. Introduction

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.3.3. Market Share Analysis
2.4. Assumption for the Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Drivers
- 4.2.1. Increasing Research Applications of Microarrays
- 4.2.2. Use of Microarrays in Cancer Research
- 4.2.3. Increasing Adoption of Personalized Medicine
- 4.2.4. Growing R&D Expenditure in Pharmaceutical and Biotechnology Industries
4.3. Restraints
- 4.3.1. Higher Costs of Microarrays as Compared to Other Genetic Testing Methods
4.4. Opportunities
- 4.4.1. Technological Advancements in Microarray Technology
- 4.4.2. Emerging Economies
4.5. Challenges
- 4.5.1. Lack of Sensitivity and Accuracy
4.6. Trends
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Value Chain Analysis

5. Global Microarray Kits Market-by Product Type

5.1. Overview
5.2. DNA Microarray Kits
- 5.2.1. cDNA Microarray Kits
- 5.2.2. Oligo Microarray Kits
- 5.2.3. BAC Microarray Kits
- 5.2.4. SNP Microarray Kits
5.3. RNA Microarray Kits
5.4. Protein Microarray Kits
5.5. Tissue Microarray Kits

6. Global Microarray Kits Market-by Application

6.1. Overview
6.2. Drug Discovery & Development
6.3. Research Applications
6.4. Diagnostics
6.5. Other Applications

7. Global Microarray Kits Market-by End User

7.1. Overview
7.2. Pharmaceutical & Biotechnology Companies
7.3. Contract Research Organizations
7.4. Research & Academic Institutes
7.5. Hospitals & Diagnostic Laboratories
7.6. Other End Users (Veterinary Clinics, Agricultural Industry, Forensic Laboratories)

8. Microarray Kits Market-by Geography

8.1. Overview
8.2. North America
- 8.2.1. U.S.
- 8.2.2. Canada
8.3. Europe
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Rest of Europe
8.4. Asia-Pacific
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Rest of Asia Pacific
8.5. Latin America
- 8.5.1. Brazil
- 8.5.2. Mexico
- 8.5.3. Rest of Latin America
8.6. Middle East & Africa

9. Competition Analysis

9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
- 9.4.1. Market Leaders
- 9.4.2. Market Differentiators
- 9.4.3. Vanguards
- 9.4.4. Emerging Companies
9.5. Market Share Analysis/Market Ranking, By Key Players (2022)

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

10.1. Thermo Fisher Scientific, Inc.
10.2. Illumina, Inc.
10.3. Agilent Technologies, Inc.
10.4. Merck KgaA
10.5. PerkinElmer, Inc.
10.6. QIAGEN N.V.
10.7. Edvotek Inc.
10.8. Sakura Finetek USA, Inc.
10.9. Dextra Laboratories Ltd
10.10. GeneCopoeia, Inc.
10.11. Other Companies

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

11. Appendix

11.1. Available Customization
11.2. Related Reports